MENU
PROK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ProKidney (PROK) Ownership - Who owns ProKidney?
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment... Show more
Profile
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
97.15M
P/E Ratio
N/A
Total Cash
358.29M
Projected Growth
N/A
Total Debt
3.24M
Revenue
76K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.77
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
PROK
Capitalization
97.2M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
358M
Total Cash/Share
2.77
Total Debt
3.24M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
76K
ROE
N/A
Book Value
-994.95M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
10.93
Current Revenue Per Employee
372.55
Dividends Per Share - Security
N/A
EBITDA
-158.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.20
Shares Held By Institutions
180M
Shares Outstanding - Current
130M
Total Liabilities
39.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-55.621
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com